BismuthSubcitrateMetronidazoleTetracycline_GastroFDCQualityChecker
Bismuth/Metronidazole/Tetracycline Gastro FDC Quality Checker
ℹ️ Utility checks critical parameters of H. pylori eradication combination:
• Bismuth Assay: 90.0–110.0%
• Metronidazole Assay: 90.0–110.0%
• Tetracycline Assay: 90.0–110.0%
• Metronidazole Impurities: ≤1.0%
• Tetracycline Impurities: ≤1.0%
• Total Impurities: ≤2.5%
• Dissolution of each component: ≥85% (Q)
• Moisture Content: ≤5.0%
• Heavy Metals: ≤20 ppm
⚠️ CRITICAL: Tetracycline is sensitive to light and moisture (epi-tetracycline formation).
Bismuth may interact with other components at high humidity.
Usage:
BismuthSubcitrateMetronidazoleTetracycline_GastroFDCQualityChecker.exe → demo mode
BismuthSubcitrateMetronidazoleTetracycline_GastroFDCQualityChecker.exe input.csv output.json → evaluate data
Input format:
BatchNumber,BismuthAssayPercent,MetronidazoleAssayPercent,TetracyclineAssayPercent,MetronidazoleImpurityPercent,TetracyclineImpurityPercent,TotalImpuritiesPercent,DissolutionMetronidazolePercent,DissolutionTetracyclinePercent,MoistureContentPercent,HeavyMetalsPPM
Example:
BMT-2026-001,100.5,99.8,100.2,0.3,0.4,0.9,95.0,92.0,3.5,8.0
— WHY IS THIS NEEDED?
Bismuth subcitrate, metronidazole, and tetracycline combination is used for Helicobacter pylori eradication:
• Bismuth subcitrate — gastroprotective and antibacterial action
• Metronidazole — antiprotozoal and antibacterial drug
• Tetracycline — broad-spectrum antibiotic
• Combination is part of first-line quadruple therapy for clarithromycin resistance
• Tetracycline is chemically unstable (epimerization, oxidation)
⚠️ CRITICAL:
• Assay 90.0–110.0% for each component — ensures eradication efficacy
• Metronidazole and Tetracycline impurities ≤1.0% — degradation and synthesis products
• Total Impurities ≤2.5% — overall purity indicator
• Dissolution ≥85% for each component — ensures bioavailability
• Moisture Content ≤5.0% — critical for tetracycline stability
• Heavy Metals ≤20 ppm — drug safety
Key features:
• Simultaneous check of three active substances with different mechanisms of action
• Individual impurity control considering tetracycline instability
• Dissolution testing for both organic components
• Moisture control as stability factor for tetracycline
Critical parameters:
• Bismuth Assay: 90.0–110.0%
• Metronidazole Assay: 90.0–110.0%
• Tetracycline Assay: 90.0–110.0%
• Metronidazole Impurities: ≤1.0%
• Tetracycline Impurities: ≤1.0%
• Total Impurities: ≤2.5%
• Dissolution (each): ≥85% (Q)
• Moisture Content: ≤5.0%
• Heavy Metals: ≤20 ppm
💡 Usage tips:
1. Assay determined by HPLC with UV detection (for organic components) and atomic absorption/titration (for bismuth)
2. Protect tetracycline from light during sample preparation
3. Tetracycline dissolution may require use of buffer media
4. Moisture determined by Karl Fischer method
5. Store in airtight packaging, protect from light
6. If high levels of tetracycline impurities detected, check raw material storage conditions (risk of toxic epi-forms)
⚠️ Note: Tetracycline is prone to epimerization forming epi-tetracycline, which is less active and more toxic. This process accelerates in humid environments and upon heating. Bismuth may form complexes with tetracycline, requiring careful control of manufacturing process and mixture homogeneity.
input.csv
BatchNumber,BismuthAssayPercent,MetronidazoleAssayPercent,TetracyclineAssayPercent,MetronidazoleImpurityPercent,TetracyclineImpurityPercent,TotalImpuritiesPercent,DissolutionMetronidazolePercent,DissolutionTetracyclinePercent,MoistureContentPercent,HeavyMetalsPPM BMT-2026-001,100.5,99.8,100.2,0.3,0.4,0.9,95.0,92.0,3.5,8.0 BMT-2026-002,98.0,101.0,99.5,0.5,0.6,1.3,93.0,90.0,4.2,10.0
BismuthSubcitrateMetronidazoleTetracycline_GastroFDCQualityChecker — Documentation
input.csv and *.description.txt. Package folder: Gastroenterology QC Suite.Utility description
Bismuth/Metronidazole/Tetracycline Gastro FDC Quality Checker — Combination Gastroenterological Product Quality Control
ℹ️ Utility checks critical parameters of H. pylori eradication combination:
• Bismuth Assay: 90.0–110.0%
• Metronidazole Assay: 90.0–110.0%
• Tetracycline Assay: 90.0–110.0%
• Metronidazole Impurities: ≤1.0%
• Tetracycline Impurities: ≤1.0%
• Total Impurities: ≤2.5%
• Dissolution of each component: ≥85% (Q)
• Moisture Content: ≤5.0%
• Heavy Metals: ≤20 ppm
⚠️ CRITICAL: Tetracycline is sensitive to light and moisture (epi-tetracycline formation).
Bismuth may interact with other components at high humidity.
Usage:
BismuthSubcitrateMetronidazoleTetracycline_GastroFDCQualityChecker.exe → demo mode
BismuthSubcitrateMetronidazoleTetracycline_GastroFDCQualityChecker.exe input.csv output.json → evaluate data
Input format:
BatchNumber,BismuthAssayPercent,MetronidazoleAssayPercent,TetracyclineAssayPercent,MetronidazoleImpurityPercent,TetracyclineImpurityPercent,TotalImpuritiesPercent,DissolutionMetronidazolePercent,DissolutionTetracyclinePercent,MoistureContentPercent,HeavyMetalsPPM
Example:
BMT-2026-001,100.5,99.8,100.2,0.3,0.4,0.9,95.0,92.0,3.5,8.0
— WHY IS THIS NEEDED?
Bismuth subcitrate, metronidazole, and tetracycline combination is used for Helicobacter pylori eradication:
• Bismuth subcitrate — gastroprotective and antibacterial action
• Metronidazole — antiprotozoal and antibacterial drug
• Tetracycline — broad-spectrum antibiotic
• Combination is part of first-line quadruple therapy for clarithromycin resistance
• Tetracycline is chemically unstable (epimerization, oxidation)
⚠️ CRITICAL:
• Assay 90.0–110.0% for each component — ensures eradication efficacy
• Metronidazole and Tetracycline impurities ≤1.0% — degradation and synthesis products
• Total Impurities ≤2.5% — overall purity indicator
• Dissolution ≥85% for each component — ensures bioavailability
• Moisture Content ≤5.0% — critical for tetracycline stability
• Heavy Metals ≤20 ppm — drug safety
Key features:
• Simultaneous check of three active substances with different mechanisms of action
• Individual impurity control considering tetracycline instability
• Dissolution testing for both organic components
• Moisture control as stability factor for tetracycline
Critical parameters:
• Bismuth Assay: 90.0–110.0%
• Metronidazole Assay: 90.0–110.0%
• Tetracycline Assay: 90.0–110.0%
• Metronidazole Impurities: ≤1.0%
• Tetracycline Impurities: ≤1.0%
• Total Impurities: ≤2.5%
• Dissolution (each): ≥85% (Q)
• Moisture Content: ≤5.0%
• Heavy Metals: ≤20 ppm
💡 Usage tips:
1. Assay determined by HPLC with UV detection (for organic components) and atomic absorption/titration (for bismuth)
2. Protect tetracycline from light during sample preparation
3. Tetracycline dissolution may require use of buffer media
4. Moisture determined by Karl Fischer method
5. Store in airtight packaging, protect from light
6. If high levels of tetracycline impurities detected, check raw material storage conditions (risk of toxic epi-forms)
⚠️ Note: Tetracycline is prone to epimerization forming epi-tetracycline, which is less active and more toxic. This process accelerates in humid environments and upon heating. Bismuth may form complexes with tetracycline, requiring careful control of manufacturing process and mixture homogeneity.URS & FS — User Requirements and Functional Specification
This document describes the controlled interface and behaviour of BismuthSubcitrateMetronidazoleTetracycline_GastroFDCQualityChecker for Bismuth/Metronidazole/Tetracycline Gastro FDC Quality Checker.
Portal packages
Gastroenterology QC Suite, Global/API coverage extension, LabEx QC laboratory utilities, Lumex QC instrument utilities, World API/FDC extension
CSV→JSONFDCGastroenterologyMissingAPIQCURS & FSP2Domain limits and critical parameters
- ℹ️ Utility checks critical parameters of H. pylori eradication combination:
- • Bismuth Assay: 90.0–110.0%
- • Metronidazole Assay: 90.0–110.0%
- • Tetracycline Assay: 90.0–110.0%
- • Metronidazole Impurities: ≤1.0%
- • Tetracycline Impurities: ≤1.0%
- • Total Impurities: ≤2.5%
- • Dissolution of each component: ≥85% (Q)
- • Moisture Content: ≤5.0%
- • Heavy Metals: ≤20 ppm
- ⚠️ CRITICAL: Tetracycline is sensitive to light and moisture (epi-tetracycline formation).
- BatchNumber,BismuthAssayPercent,MetronidazoleAssayPercent,TetracyclineAssayPercent,MetronidazoleImpurityPercent,TetracyclineImpurityPercent,TotalImpuritiesPercent,DissolutionMetronidazolePercent,DissolutionTetracyclinePercent,MoistureContentPercent,HeavyMetalsPPM
- ⚠️ CRITICAL:
- • Assay 90.0–110.0% for each component — ensures eradication efficacy
- • Metronidazole and Tetracycline impurities ≤1.0% — degradation and synthesis products
- • Total Impurities ≤2.5% — overall purity indicator
- • Dissolution ≥85% for each component — ensures bioavailability
- • Moisture Content ≤5.0% — critical for tetracycline stability
URS — User Requirements Specification
| ID | Requirement | Criticality | Acceptance criterion |
|---|---|---|---|
| URS-001 | The utility shall accept an input.csv file for Bismuth/Metronidazole/Tetracycline Gastro FDC Quality Checker with headers defined in the data contract. | High | The file is processed without manual header editing. |
| URS-002 | The utility shall perform deterministic QC evaluation without machine learning and without probabilistic conformance decisions. | High | Identical input data, rule version and configuration produce reproducible results. |
| URS-003 | The utility shall validate mandatory fields, data types, ranges, units and domain plausibility. | High | Schema, conversion and range errors are explicitly reported. |
| URS-004 | The utility shall apply domain limits and rules from the description, approved specification, registration dossier and local SOPs. | High | Each check has PASS/WARNING/FAIL and a clear message. |
| URS-005 | The utility shall generate output.json with machine-readable results, source values, warnings, failures and critical findings. | High | JSON is suitable for LIMS/ELN/MES integration and QA/QC review. |
| URS-006 | The utility shall preserve traceability between batch/sample, input file, applied rules and final status. | High | Output contains identifiers, checked parameters and audit metadata. |
| URS-007 | The documentation shall support IQ/OQ/PQ, CSV/CSA and review by internal QA or inspectors. | Medium | URS, FS, input/output contract and test scenarios are supplied with the utility. |
| URS-008 | The utility shall be used as a QC decision-support tool and not as a substitute for approved specifications and QA/QP release decision. | Medium | Documentation states change control and limit-verification expectations. |
input.csv contract
| # | Field | Type | Sample | Purpose |
|---|---|---|---|---|
| 1 | BatchNumber | string / controlled vocabulary | BMT-2026-001 | Batch or lot identifier used for traceability. |
| 2 | BismuthAssayPercent | decimal | 100.5 | Quantitative content/potency; critical release parameter. |
| 3 | MetronidazoleAssayPercent | decimal | 99.8 | Quantitative content/potency; critical release parameter. |
| 4 | TetracyclineAssayPercent | decimal | 100.2 | Quantitative content/potency; critical release parameter. |
| 5 | MetronidazoleImpurityPercent | decimal | 0.3 | Impurity/related-substance parameter; purity and degradation control. |
| 6 | TetracyclineImpurityPercent | decimal | 0.4 | Impurity/related-substance parameter; purity and degradation control. |
| 7 | TotalImpuritiesPercent | decimal | 0.9 | Impurity/related-substance parameter; purity and degradation control. |
| 8 | DissolutionMetronidazolePercent | decimal | 95.0 | Dissolution/release parameter relevant to bioavailability and batch quality. |
| 9 | DissolutionTetracyclinePercent | decimal | 92.0 | Dissolution/release parameter relevant to bioavailability and batch quality. |
| 10 | MoistureContentPercent | decimal | 3.5 | Quantitative content/potency; critical release parameter. |
| 11 | HeavyMetalsPPM | decimal | 8.0 | Elemental impurity/metal parameter relevant to safety. |
BatchNumber,BismuthAssayPercent,MetronidazoleAssayPercent,TetracyclineAssayPercent,MetronidazoleImpurityPercent,TetracyclineImpurityPercent,TotalImpuritiesPercent,DissolutionMetronidazolePercent,DissolutionTetracyclinePercent,MoistureContentPercent,HeavyMetalsPPM BMT-2026-001,100.5,99.8,100.2,0.3,0.4,0.9,95.0,92.0,3.5,8.0 BMT-2026-002,98.0,101.0,99.5,0.5,0.6,1.3,93.0,90.0,4.2,10.0
Input validation rules
| ID | Field | Rule | Criticality |
|---|---|---|---|
| VR-001 | BatchNumber | The field shall match an approved dictionary or accepted string representation. | High |
| VR-002 | BismuthAssayPercent | The value shall be numeric, non-empty and domain-plausible for the approved specification. | High |
| VR-003 | MetronidazoleAssayPercent | The value shall be numeric, non-empty and domain-plausible for the approved specification. | High |
| VR-004 | TetracyclineAssayPercent | The value shall be numeric, non-empty and domain-plausible for the approved specification. | High |
| VR-005 | MetronidazoleImpurityPercent | The value shall be numeric, non-empty and domain-plausible for the approved specification. | High |
| VR-006 | TetracyclineImpurityPercent | The value shall be numeric, non-empty and domain-plausible for the approved specification. | High |
| VR-007 | TotalImpuritiesPercent | The value shall be numeric, non-empty and domain-plausible for the approved specification. | High |
| VR-008 | DissolutionMetronidazolePercent | The value shall be numeric, non-empty and domain-plausible for the approved specification. | Medium |
| VR-009 | DissolutionTetracyclinePercent | The value shall be numeric, non-empty and domain-plausible for the approved specification. | Medium |
| VR-010 | MoistureContentPercent | The value shall be numeric, non-empty and domain-plausible for the approved specification. | High |
| VR-011 | HeavyMetalsPPM | The value shall be numeric, non-empty and domain-plausible for the approved specification. | Medium |
FS — Functional Specification
| ID | Function | Implementation |
|---|---|---|
| FS-001 | CLI execution | Support execution modes: demo mode without arguments and production mode input.csv output.json. |
| FS-002 | CSV import | Read input.csv in UTF-8/CSV-compatible format and validate header and expected columns. |
| FS-003 | Schema validation | Check mandatory fields, column count, unknown key fields and empty mandatory values. |
| FS-004 | Type conversion | Convert numeric, flag and text values; invalid format is recorded as a row-level error. |
| FS-005 | Domain rule engine | Apply rules for Bismuth/Metronidazole/Tetracycline Gastro FDC Quality Checker, including critical limits from the description and approved specification. |
| FS-006 | Status aggregation | Produce final status: FAIL for critical failure, WARNING for non-critical deviation, PASS for conformance. |
| FS-007 | JSON export | Write output.json with detailed checks, source values, warnings, failures and critical findings. |
| FS-008 | Audit support | Keep result structure suitable for review, deviation investigation and calculation reproduction. |
| FS-009 | Integration contract | Support the scenario LIMS/ELN/MES → input.csv → utility → output.json → portal/admin review. |
| FS-010 | Fallback mapping | If the combined utility is not deployed, use component checks: bismuth-subcitrate-quality-checker, metronidazole-quality-checker, tetracycline-quality-checker plus generic Lumex/LabEx checks. |
| FS-011 | Error handling | Return explicit messages for missing file, empty CSV, invalid schema, output write failure and invalid format. |
Example output.json
{
"utilityId": "bismuth-subcitrate-metronidazole-tetracycline-gastro-fdc-quality-checker",
"utilityFolder": "BismuthSubcitrateMetronidazoleTetracycline_GastroFDCQualityChecker",
"package": "Gastroenterology QC Suite",
"overallStatus": "PASS|WARNING|FAIL",
"sourceFile": "input.csv",
"processedAtUtc": "2026-07-02T00:00:00Z",
"checks": [
{
"parameter": "BatchNumber",
"value": "BMT-2026-001",
"status": "PASS|WARNING|FAIL",
"message": "Deterministic rule-based check result",
"ruleReference": "FS-RULE-001"
},
{
"parameter": "BismuthAssayPercent",
"value": "100.5",
"status": "PASS|WARNING|FAIL",
"message": "Deterministic rule-based check result",
"ruleReference": "FS-RULE-002"
},
{
"parameter": "MetronidazoleAssayPercent",
"value": "99.8",
"status": "PASS|WARNING|FAIL",
"message": "Deterministic rule-based check result",
"ruleReference": "FS-RULE-003"
},
{
"parameter": "TetracyclineAssayPercent",
"value": "100.2",
"status": "PASS|WARNING|FAIL",
"message": "Deterministic rule-based check result",
"ruleReference": "FS-RULE-004"
},
{
"parameter": "MetronidazoleImpurityPercent",
"value": "0.3",
"status": "PASS|WARNING|FAIL",
"message": "Deterministic rule-based check result",
"ruleReference": "FS-RULE-005"
},
{
"parameter": "TetracyclineImpurityPercent",
"value": "0.4",
"status": "PASS|WARNING|FAIL",
"message": "Deterministic rule-based check result",
"ruleReference": "FS-RULE-006"
},
{
"parameter": "TotalImpuritiesPercent",
"value": "0.9",
"status": "PASS|WARNING|FAIL",
"message": "Deterministic rule-based check result",
"ruleReference": "FS-RULE-007"
},
{
"parameter": "DissolutionMetronidazolePercent",
"value": "95.0",
"status": "PASS|WARNING|FAIL",
"message": "Deterministic rule-based check result",
"ruleReference": "FS-RULE-008"
},
{
"parameter": "DissolutionTetracyclinePercent",
"value": "92.0",
"status": "PASS|WARNING|FAIL",
"message": "Deterministic rule-based check result",
"ruleReference": "FS-RULE-009"
},
{
"parameter": "MoistureContentPercent",
"value": "3.5",
"status": "PASS|WARNING|FAIL",
"message": "Deterministic rule-based check result",
"ruleReference": "FS-RULE-010"
},
{
"parameter": "HeavyMetalsPPM",
"value": "8.0",
"status": "PASS|WARNING|FAIL",
"message": "Deterministic rule-based check result",
"ruleReference": "FS-RULE-011"
}
],
"criticalFindings": [],
"warnings": [],
"audit": {
"inputHash": "sha256:<calculated at runtime>",
"rulesVersion": "<utility executable version>",
"documentation": "BismuthSubcitrateMetronidazoleTetracycline_GastroFDCQualityChecker.documentation.html"
}
}
Traceability matrix
| URS | FS | Test | Evidence |
|---|---|---|---|
| URS-001 | FS-001, FS-002 | OQ-001 | Verify execution and import of valid input.csv. |
| URS-002 | FS-005, FS-006 | OQ-004 | Repeat the same dataset and compare output.json. |
| URS-003 | FS-003, FS-004, FS-011 | OQ-002, OQ-003 | Verify missing columns and invalid types. |
| URS-004 | FS-005, FS-006 | OQ-004, PQ-001 | Verify critical deviations on real/boundary data. |
| URS-005 | FS-007, FS-009 | OQ-005 | Verify JSON schema and downstream-system suitability. |
| URS-006 | FS-008 | OQ-006 | Verify identifiers and audit metadata. |
| URS-007 | FS-008, FS-011 | IQ-001, OQ-007 | Verify documentation completeness and control evidence. |
| URS-008 | FS-005, FS-008, FS-010 | PQ-002 | Verify review workflow and no replacement of QA decision. |
IQ/OQ/PQ test scenarios
| ID | Scenario | Expected result |
|---|---|---|
| IQ-001 | Verify executable, input.csv, documentation and checksum availability. | Delivery set is complete; version is recorded. |
| OQ-001 | Valid sample row from input.csv. | PASS or acceptable WARNING according to rules. |
| OQ-002 | Remove a mandatory CSV column. | Schema error or FAIL with missing-column reference. |
| OQ-003 | Place a non-numeric value into a numeric field. | Type-conversion error with row/field reference. |
| OQ-004 | Set a critical parameter outside the limit. | FAIL and critical finding. |
| OQ-005 | Verify output.json structure. | All mandatory sections are present and JSON is valid. |
| OQ-006 | Verify batch/sample traceability. | Input and result identifiers match. |
| OQ-007 | Verify fallback/decomposition for combined APIs. | Component checks are explicitly documented. |
| PQ-001 | Verify 3–5 real user batches/samples. | Result is confirmed by QC/QA review. |
| PQ-002 | Verify deviation workflow and manual QA decision. | Utility supports review but does not replace approved decision. |
QA/QC and change control
- Do not rename columns without updating validator, documentation and test set.
- Retain input.csv, output.json, executable version and checksum.
- Before production use, perform IQ/OQ/PQ or equivalent CSV/CSA verification.
- Critical limits shall be verified against the approved specification, registration dossier and local SOPs.
- For combination products, document whether the specialized FDC utility or fallback component checks were used.
- The utility provides structured QC decision support; final release decision remains with QA/QP and approved procedures.
Included in packages
Gastroenterology QC Suite
QC package for gastroenterology: PPIs, antiemetics, prokinetics, IBD medicines, laxatives, enzymes and GI anti-infectives.
OpenGlobal API & Biosimilars QC Suite
Package for high-demand global APIs, generics and biosimilars, including fixed-dose combinations and biological products.
OpenWorld API Extension QC Suite
Extended package for 130 additional high-demand APIs and biological products prepared as a market-coverage backlog.
Open